What Are The Research Benefits of CJC-1295 DAC
Enhanced Growth Hormone Secretion: Promotes increased endogenous secretion of growth hormone, mimicking natural pulsatile release patterns. This function plays a vital role in the increase of muscle mass and strength, potentially aiding in the increase of lean muscle mass and improving physical performance.
Prolonged Action: The extended half-life allows for less frequent injections, which can enhance patient adherence to treatment protocols. Canada Canada Research indicates that, with the addition of DAC (Drug Affinity Complex), CJC-1295 possesses a longer half-life than other peptides, resulting in sustained effects in the body.
Optimised Treatment Protocols: The flexibility in dosage and administration frequency supports tailored therapeutic approaches, catering to individual patient needs.
Promotion of Protein Synthesis: Research shows it helps boost protein synthesis, an important process for muscle hypertrophy and recovery.
Metabolic Support: This peptide may assist in fat reduction and promote a leaner body composition while enhancing muscle mass. Canada Studies indicate that the peptide aids in lipolysis, the process through which the body breaks down fats for energy.
Increased Bone Density: Growth hormone significantly contributes to bone health, and this peptide may stimulate its production, potentially increasing bone density and reducing the risk of fractures and osteoporosis.
Improved Serum Protein Profile: Alters serum albumin concentrations, which contributes positively to overall metabolic health.
Enhanced Skin Health: Canada Scientific studies suggest that by stimulating growth hormone production, it may promote healthier skin, aiding in cell regeneration and repair, and increased collagen production, leading to improved skin elasticity and reduced wrinkles.
Improved Sleep: As an analogue of growth hormone releasing hormone (GHRH), Canada research has suggested that it may enhance sleep patterns by affecting the sleep-wake cycle.
Cognitive Enhancement: Emerging research suggests that the compound may have positive effects on cognitive function, potentially enhancing memory, focus, and overall mental clarity by promoting growth hormone levels that support neuronal health and regeneration.
Anti-Aging Properties: The peptide may provide potential benefits in mitigating the signs of aging through improved body composition and increased vitality.
Reduced Side Effects: In comparison to exogenous GH administration, the peptide may exhibit fewer adverse effects, such as transient hypotension or injection site reactions.
Therapeutic Agent: It holds possible applications in managing various metabolic disorders, including obesity and sarcopenia, demonstrating its versatility in treatment strategies.
Buy CJC-1295 DAC peptide vial available in 2mg, 5mg, and 10mg glass vials for research purposes online from Direct Peptides Canada today!
References For Further Reading
(1) Volpe A, Coukos G, Barreca A, Giordano G, Artini P G, Genazzani A R (1991) Clinical use of growth hormone-releasing factor for induction of superovulation – Human Reproduction, Volume 6, Issue 9, 1 Oct 1991, Pages 1228–1232.
(2) Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA (2006) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults – J Clin Endocrinol Metab, 2006 Mar, Volume 91 (Issue 3), Pages 799-805.
(3) Ionescu M and Frohman L A (2006) Pulsatile Secretion of Growth Hormone (GH) Persists during Continuous Stimulation by CJC-1295, a Long-Acting GH-Releasing Hormone Analog – The Journal of Clinical Endocrinology & Metabolism, Volume 91, Issue 12, 1 December 2006, Pages 4792–4797.
(4) Sackmann-Sala L, Ding J, Frohman L A, Kopchick J J (2009) Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects – Growth Hormone and IGF Research, 2009 Dec, Volume 19 (Issue 6), Pages 471-7.
(5) Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R (2006) Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse – American Journal of Physiology. Endocrinology and Metabolism, 2006 Dec, Volume 291 (Issue 6), Pages E1290-4.
(6) M C van Hout and E Hearne (2016) Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions – Substance Use & Misuse, 2 Jan 2016, Volume 51, 2016 – Issue 1, Pages 73-84.